Related references
Note: Only part of the references are listed.Is contrast material needed after treatment of malignant lymphoma in positron emission tomography/computed tomography?
Yuji Nakamoto et al.
ANNALS OF NUCLEAR MEDICINE (2011)
Neuroendocrine Tumors: Current Recommendations for Diagnosis and Surgical Management
Saju Joseph et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
Standard Imaging Techniques for Neuroendocrine Tumors
David L. Bushnell et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Ben Lawrence et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT
Thomas Pfluger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component
Patrick Veit-Haibach et al.
EUROPEAN RADIOLOGY (2011)
Role of 68Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours
Rakesh Kumar et al.
EUROPEAN RADIOLOGY (2011)
Imaging of Carcinoid Tumors: Spectrum of Findings With Pathologic and Clinical Correlation
Khaled M. Elsayes et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2011)
68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol
Juri Ruf et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Incidence of Increased 68Ga-DOTANOC Uptake in the Pancreatic Head in a Large Series of Extrapancreatic NET Patients Studied with Sequential PET/CT
Paolo Castellucci et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence
Kazuhiro Kitajima et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
Valentina Ambrosini et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
A Systematic Review of Diagnostic Procedures to Detect Midgut Neuroendocrine Tumors
Marco Scarpa et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Impact of Multiphase Ga-68-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
Juri Ruf et al.
NEUROENDOCRINOLOGY (2010)
Iodinated Contrast Media and Their Adverse Reactions
Jagdish Singh et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2008)
A fully automated synthesis for the preparation of 68Ga-labelled peptides
Clemens Decristoforo et al.
NUCLEAR MEDICINE COMMUNICATIONS (2007)
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
Michael Gabriel et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Radiolabelling DOTA-peptides with 68Ga
WAP Breeman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
JC Reubi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)